Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ALXO | A | ALX Oncology Holdings Inc. | -0.89 | |
ANL | A | Adlai Nortye Ltd. | 16.43 | |
IBRX | B | ImmunityBio, Inc. | 7.33 | |
INDP | B | Indaptus Therapeutics, Inc. | -6.35 | |
SNSE | B | Sensei Biotherapeutics, Inc. | -1.31 | |
CADL | B | Candel Therapeutics, Inc. | -5.31 | |
EVAX | B | Evaxion Biotech A/S | 2.13 | |
HOWL | B | Werewolf Therapeutics, Inc. | 0.51 | |
XLO | C | Xilio Therapeutics, Inc. | -10.16 | |
GNTA | C | Genenta Science S.p.A. | -0.37 |
Related Industries: Biotechnology Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 1.0 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.79 | |
ISMD | C | Inspire Small/Mid Cap Impact ETF | 0.29 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.17 | |
IWC | C | iShares Microcap ETF | 0.15 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles